Vistin Pharma ASA (OSL:VISTN)

Norway flag Norway · Delayed Price · Currency is NOK
21.10
+0.60 (2.93%)
At close: Jan 30, 2026
-11.34%
Market Cap913.50M -10.4%
Revenue (ttm)455.25M +6.7%
Net Income78.06M +27.2%
EPS1.76 +27.2%
Shares Out44.34M
PE Ratio11.70
Forward PEn/a
Dividend1.25 (5.92%)
Ex-Dividend Daten/a
Volume2,345
Average Volume12,026
Open21.30
Previous Close20.50
Day's Range20.90 - 21.30
52-Week Range19.40 - 27.30
Beta0.66
RSI54.39
Earnings DateFeb 12, 2026

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway. [Read more]

Sector Healthcare
Founded 1969
Employees 75
Stock Exchange Oslo Børs
Ticker Symbol VISTN
Full Company Profile

Financial Performance

In 2024, Vistin Pharma ASA's revenue was 429.50 million, a decrease of -2.01% compared to the previous year's 438.33 million. Earnings were 62.75 million, an increase of 37.62%.

Financial Statements